Search filters

List of works by Teresa Gamucci

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer

scientific article published on 22 July 2016

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

scientific article published on 11 November 2016

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

scientific article

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

AIDS-related non-Hodgkin's lymphoma: clinico-pathological characteristics and therapeutic strategies (review).

scientific article

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

scientific article

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

scientific article published on 28 March 2016

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting

scientific article published on 9 April 2017

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons

scientific article published on 23 August 2016

Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study

scientific article

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

scientific article published on 9 October 2015

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

scientific article published on 16 January 2018

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

scientific article

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

scientific article

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

scientific article

Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?

scientific article published on 25 April 2013

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 January 2019

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

scientific article published on 25 September 2015

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

scientific article

Darbepoetin alpha coming of age.

scientific article

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study

scientific article

Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey

scientific article published on 27 September 2016

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

scientific article published on 12 December 2018

Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

scientific article published on 04 July 2020

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

scientific article published on 12 May 2015

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial

scientific article published on July 2011

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

scientific article published on 20 April 2013

Efficacy of pertuzumab in combination with trastuzumab and a taxane in first-line treatment for metastatic breast cancer (MBC): A multicenter, retrospective, observational study

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control

scientific article

Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.

scientific article published on 20 March 2014

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis

scientific article

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.

scientific article published on 7 April 2017

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

scientific article

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

scientific article published on 6 September 2017

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer

scientific article published on July 2013

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

scientific article published on 2 March 2015

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

scientific article published on 20 April 2017

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

scientific article published on 22 October 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

scientific article published on 15 January 2020

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

scientific article published on 15 October 2019

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

scientific article

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey

scientific article

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

scientific article published on 15 July 2017

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients

scientific article

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

scientific article

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial

scientific article published on December 2015

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer

scientific article

Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).

scientific article published on 19 December 2016

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

scientific article published on 17 October 2015

Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?

scientific article published on 16 May 2017

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

scientific article

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

scientific article published on 4 September 2015

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

scientific article published on 2 April 2016

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis

scientific article published on 21 July 2016

Triple positive breast cancer: a distinct subtype?

scientific article published on 19 December 2014

Paulina is supported by:

About Paulina

Help